Tag Archives: Amgen

Amgen Changes Pricing Policy for Aranesp

As of October 1, 2008 Amgen will no longer offer rebates to oncologists and oncology clinics who purchase Aranesp® (darbepoetin alfa) although they will provide larger discounts at the time of purchase. They also will no longer base discounts for Neulasta® (pegfilgrastim) and Neupogen© (filgrastim) on purchases of Aranesp, a process known as bundling.  Neulasta and Neupogen help raise white cell counts lowered by chemotherapy and are designed to prevent infection resulting from treatment. Nancy Roach, Chairperson of the C3: Colorectal Cancer Coalition, told the New York Times, It’s a step in the right direction. In addition, she told C3 Research News that C3 supports fair pricing policies for drugs